A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo

Last updated:
2026-07-18
Language and content disclaimer

The content and search results on this site are collected from or provided by third parties. As such some of the information may only be available in the language originally submitted by the sponsor of the trial. Learn more about the information on the search portal.

Linking to Non-Government of Canada Websites

Links to websites not under the control of the Government of Canada, including those to our social media accounts, and to clinical trial records in international registries are provided solely for the convenience of our website visitors. We are not responsible for the accuracy, currency or reliability of the content of such websites. The Government of Canada does not offer any guarantee in that regard and is not responsible for the information found through these links, nor does it endorse the sites and their content.

Visitors should also be aware that information offered by non-Government of Canada sites to which this website links is not subject to the Privacy Act or the Official Languages Act and may not be accessible to persons with disabilities. The information offered may be available only in the language(s) used by the sites in question. With respect to privacy, visitors should research the privacy policies of these non-government websites before providing personal information.

View trial details

Overview

Official protocol title:

A PHASE 2, RANDOMIZED, 24-WEEK, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED PROOF-OF-CONCEPT STUDY TO INVESTIGATE EFFICACY AND SAFETY OF LY4005130 IN ADULT PARTICIPANTS WITH NON-SEGMENTAL VITILIGO

Intervention/treatment:
LY4005130
Medical condition:
VITILIGO
Protocol code:
J5D-MC-FPAD
Control number:
500009
Status:
Recruiting
Approved:
April 14, 2026
Trial phase:
Phase 2
For more information:
ClinicalTrials.gov - NCT07533019
This is an external link. The information is not authorized by the Government of Canada.

Eligibility

Sex: ALL
Age
18 Years to 75 Years
Accepts healthy volunteers: No

Contacts and locations

Contact
Name
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or
Role
CONTACT
Phone:
1-317-615-4559
Name
Physicians interested in becoming principal investigators please contact
Role
CONTACT
Sponsor
ELI LILLY CANADA INC

Locations

Dar Clinical Research - Ottawa - Hunt Club Road
Ottawa, K1V 1C1
RECRUITING
Name
Reetesh Bose
Role
PRINCIPAL_INVESTIGATOR
DermEffects
London, N6H 5L5
NOT_YET_RECRUITING
Role
CONTACT
Phone:
519-204-6868
Name
Wei Jing Loo
Role
PRINCIPAL_INVESTIGATOR
INTERMED Groupe Sante
Chicoutimi, G7H 7Y8
RECRUITING
Role
CONTACT
Phone:
418-602-6620
Name
Doria Grimard
Role
PRINCIPAL_INVESTIGATOR
Research Toronto
Toronto, M4W 2N4
NOT_YET_RECRUITING
Role
CONTACT
Phone:
4169620123
Name
Sameh Hanna
Role
PRINCIPAL_INVESTIGATOR
SIMa Recherche
Verdun, H4G 2L8
NOT_YET_RECRUITING
Role
CONTACT
Phone:
5147308398
Name
Simon Nigen
Role
PRINCIPAL_INVESTIGATOR
The Centre for Dermatology
Richmond Hill, L4B 1A5
NOT_YET_RECRUITING
Name
Mani Raman
Role
PRINCIPAL_INVESTIGATOR
Did you find what you were looking for?

Contacts and resources